| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |